Mark Tobin
LIGHTBRIDGEAbout Mark Tobin
Mark Tobin (age 51) has served as an independent director of Lightbridge Corporation since September 2021. He is a global finance and strategy executive with 28+ years of experience across international investment banking and public-company leadership, and currently serves as CEO and CFO of Camp Facility Services. He graduated with honors from the U.S. Air Force Academy (B.S., Management) and holds an MBA from the University of Pittsburgh .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Camp Facility Services | Chief Executive Officer & Chief Financial Officer | Jul 2024–present | Leads finance and corporate strategy at national restoration/renovation services provider . |
| Camp Facility Services | Chief Financial Officer | Oct 2023–Jul 2024 | Transitioned to CEO/CFO in 2024 . |
| National Underground Group | Chief Financial Officer | 2021–2023 | CFO for underground infrastructure technology firm . |
| Printronix | Chief Financial Officer | 2017–2021 | CFO of global industrial printer manufacturer . |
| Nanoflex Power Corporation | EVP & Chief Financial Officer | 2013–2017 | Publicly listed solar technology company . |
| Roth Capital Partners | Director of Research / Senior Research Analyst | Prior to 2013 | Covered small-caps including nuclear, wind, solar, T&D; built energy infrastructure expertise . |
| SAIC | Senior Systems Engineer & Project Manager | Prior | Led systems engineering/integration for USAF programs . |
| U.S. Air Force | Officer | Early career | Oversaw advanced technology development; NATO delegate . |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Qualstar Corporation (public) | Director | 2020–2021 | Data storage solutions provider . |
| Innovation Pharmaceuticals Inc. (public) | Director | 2015–2018 | Biopharma company . |
Board Governance
| Attribute | Details |
|---|---|
| Independence | Board determined Mr. Tobin is independent under SEC and Nasdaq rules . |
| Committee assignments (2024–2025) | Audit Committee member; Compensation Committee Chair . |
| Meeting activity in 2024 | Board: 4 meetings; Audit Committee: 4; Compensation Committee: 5; Governance & Nominating: 4 . |
| Attendance | Each director attended at least 75% of Board and applicable committee meetings in 2024 . |
| Lead independent director | Daniel B. Magraw serves as Lead Independent Director . |
| Related-party transactions | None involving directors/officers/5% holders requiring disclosure (Item 404) . |
| Conflicts controls | Audit Committee (of which Mr. Tobin is a member) pre-approves related-party transactions . |
| Anti-hedging/pledging policy | Directors prohibited from hedging, shorting, or pledging Lightbridge stock . |
Fixed Compensation
| Component | 2024 | 2025 | Notes |
|---|---|---|---|
| Annual Board cash retainer | $65,000 | $70,000 | Paid quarterly. |
| Committee chair fees | Audit Chair: $11,000 (only Audit Chair received extra in 2024) | Audit Chair: $12,000; Compensation Chair: $8,000; Nominating/Gov Chair: $6,000 | Mr. Tobin is Compensation Chair (eligible for $8,000 in 2025) . |
| Committee member fees | None for non-chairs | None for non-chairs | — |
Performance Compensation
| Equity Element | Grant/Value | Shares/Price | Vesting | Notes |
|---|---|---|---|---|
| Annual director RSAs (FY2024 service) | $100,000 grant value per director | 17,183 shares at $5.82 grant-date price | Company discloses annual director RSAs “vest in full after one year of service”; 2025 policy: vest quarterly and in full after one year | Shares were issued on Jan 2, 2025 pursuant to December 2024 awards . |
No director performance metrics apply to these RSAs (time-based vesting). For executives, the 2020 Omnibus Plan allows performance-based awards and provides double-trigger vesting on change of control; awards are subject to clawback policy and plan clawback acceptance .
Other Directorships & Interlocks
| Item | Disclosure |
|---|---|
| Current public company boards | None disclosed beyond Lightbridge . |
| Prior public company boards | Qualstar Corporation (2020–2021); Innovation Pharmaceuticals Inc. (2015–2018) . |
| Compensation Committee interlocks | None in 2024 (no reciprocal executive/director overlaps) . |
Expertise & Qualifications
- Global finance and strategy leader with CFO and CEO/CFO experience in industrials/infrastructure; prior small-cap equity research coverage across nuclear, wind, solar, T&D supports sector-relevant oversight .
- Technical/operations background from USAF and SAIC, including program leadership in advanced technologies and NATO representation .
- Education: B.S. Management, U.S. Air Force Academy (honors); MBA, University of Pittsburgh .
Equity Ownership
| Holder | Shares Beneficially Owned | % of Common | Pledged Shares |
|---|---|---|---|
| Mark Tobin | 47,038 | <1% (denoted “*”) | None; table notes no pledges; policy prohibits pledging |
Governance Assessment
- Board effectiveness: Tobin chairs the Compensation Committee and sits on Audit—two critical committees for pay oversight and financial controls. 2024 committee activity was robust (Audit 4x; Comp 5x), and attendance thresholds were met, supporting engagement and effectiveness .
- Independence and conflicts: Board-determined independent; Audit Committee oversees related-party reviews; company reports no related-party transactions—low conflict risk profile .
- Director pay and alignment: Cash retainer increases modestly in 2025; equity grants of $100k in RSAs with one-year vesting maintain alignment. Anti-hedging/pledging policy reinforces long-term alignment and reduces risk of misaligned incentives .
- Shareholder sentiment context: Say-on-pay supported by 81.6% in 2024; Compensation Committee (which Tobin chairs) engaged with investors and uses an independent consultant (Pay Governance), indicating responsiveness and rigor in pay governance .
- RED FLAGS: None disclosed relating to Tobin—no related-party transactions, no pledging/hedging, no Section 16 delinquencies cited for him, and attendance met board standards .